OCT Angiography Drived Alterations in Thyroid-associated Orbitopathy
TAO
Effect of Morphological Orbital Changes on the Retinal Vascular Layers in Patients With Thyroid-associated Orbiopathy
1 other identifier
observational
68
1 country
1
Brief Summary
The aim of this observational study is to evaluate retinal microvascular alterations in patients with thyroid-associated orbitopathy (TAO) using optical coherence tomography angiography (OCTA). The specific objectives are:
- To assess the impact of extraocular muscle (EOM) enlargement on vessel density in the superficial and deep retinal capillary plexuses in patients with TAO.
- To determine the effect of increased orbital fat volume on superficial and deep retinal vessel density in TAO.
- To evaluate the relationship between disease activity, as measured by the Clinical Activity Score (CAS), and retinal microvascular density in patients with TAO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedJanuary 14, 2026
December 1, 2025
6 months
December 22, 2025
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retinal vessel density (VD)
Vessel density reflects the proportion of perfused vasculature within a defined retinal area and serves as a quantitative marker of retinal microcirculation. VD was evaluated separately in the superficial capillary plexus and the deep capillary plexus across the whole image as well as within the foveal, parafoveal, and perifoveal regions. Changes in vessel density were used to characterize microvascular alterations associated with thyroid-associated orbitopathy compared to healthy patients and to explore their relationship with disease activity and orbital structural parameters in TAO patients.
Baseline
Study Arms (2)
Patients with TAO
The study cohort consisted of patients diagnosed with TAO of varying activity and duration. All subjects were Caucasian without other significant ocular comorbidities that could confound retinal microvascular measurements. Patients with TAO were classified based on MRI characteristics into three subgroups: fat-predominant, muscle-predominant, and mixed type.
Control group
Participants without TAO or other significant ocular comorbidities were included. All subjects were Caucasian and were age- and gender-matched to the TAO patient group.
Eligibility Criteria
Patients with TED followed at Department of Ophthalmology, University Hospital Osijek, Department of Ophthalmology, Croatia.
You may qualify if:
- adult patients (≥18 years) of both sexes with a confirmed diagnosis of TAO treated at University Hospital Osijek.
You may not qualify if:
- anterior segment pathology (e.g., central keratopathy),
- primary open- or closed-angle glaucoma,
- posterior segment disorders (e.g., diabetic retinopathy, age-related macular degeneration, retinal vascular occlusion),
- previous ocular trauma or uveitis,
- refractive errors exceeding ±6.0 Diopter sphere or ±3.0 Diopter cylinder
- media opacities that compromised angio optical OCTA image quality,
- contraindication for orbital MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Osijek
Osijek, 31000, Croatia
Related Publications (4)
Mihailovic N, Lahme L, Rosenberger F, Hirscheider M, Termuhlen J, Heiduschka P, Grenzebach U, Eter N, Alnawaiseh M. ALTERED RETINAL PERFUSION IN PATIENTS WITH INACTIVE GRAVES OPHTHALMOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Endocr Pract. 2020 Mar;26(3):312-317. doi: 10.4158/EP-2019-0328. Epub 2019 Dec 20.
PMID: 31859550BACKGROUNDYu L, Jiao Q, Cheng Y, Zhu Y, Lin Z, Shen X. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmol. 2020 Oct 20;20(1):421. doi: 10.1186/s12886-020-01692-7.
PMID: 33081749BACKGROUNDYe L, Zhou SS, Yang WL, Bao J, Jiang N, Min YL, Yuan Q, Tan G, Shen M, Shao Y. RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY. Endocr Pract. 2018 Jul;24(7):658-667. doi: 10.4158/EP-2017-0229.
PMID: 30048168BACKGROUNDWu H, Song Q, Zhang Y, Cheng R, Li Y, Su M, Zhang X, Sun X. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) for assessing thyroid-associated ophthalmopathy activity. Photodiagnosis Photodyn Ther. 2025 Jun;53:104578. doi: 10.1016/j.pdpdt.2025.104578. Epub 2025 Apr 3.
PMID: 40187512BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 14, 2026
Study Start
December 9, 2024
Primary Completion
June 15, 2025
Study Completion
July 30, 2025
Last Updated
January 14, 2026
Record last verified: 2025-12